Localization and characterization of the novel protein encoded by C20orf3

被引:26
作者
Ilhan, Aysegul [1 ]
Gartner, Wolfgang [1 ]
Nabokikh, Anastasiya
Daneva, Teodora [2 ]
Majdic, Otto [3 ]
Cohen, Gerald [1 ]
Boehmig, Georg A. [1 ]
Base, Wolfgang [1 ]
Hoerl, Walter H. [1 ]
Wagner, Ludwig [1 ]
机构
[1] Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, A-1090 Vienna, Austria
[2] Bulgarian Acad Sci, BU-1113 Sofia, Bulgaria
[3] Med Univ Vienna, Inst Immunol, A-1090 Vienna, Austria
关键词
C20orf3; gene cloning; lactonohydrolase; paraoxonase (PON); protein purification; strictosidine synthase;
D O I
10.1042/BJ20080503
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, we characterized the gene product of open reading frame 3 encoded at human chromosome 20 (C20orf3), which represents it member of the lactonohydrolase Super family. Multiple-tissue Northern blot analysis showed ubiquitous expression of the 2.4 kb transcript coding for 416 amino acids, with highest levels in human liver, placenta and kidney. After recombinant production of protein variants in Escherichia coli and insect cells, antibodies directed against different epitopes within the C20orf3 gene product were generated. Using these immunoreagents, protein expression was demonstrated in the liver, and glomerular and tubular structures of the kidney, as well as in endothelial cells and arterial wall. Positive staining was also observed at the pancreatic islets of Langerhans. Using immunoblotting, we identified three size variants. In line with the results of in silico analysis demonstrating a single transmembrane sequence (amino acids 40-61) at the N-terminus of the full-length protein, FACS cell-surface staining confirmed a mainly extracellular localization of the full-length protein. Sucrose density gradient cell fractionation revealed membrane association of the dominant 50 kDa variant in HepG2 and Rin-5F cells. The finding of a strong arylesterase activity with beta-naphthyl acetate and phenyl acetate of the C20orf3 protein-containing fractions suggests potential involvement of this protein in enzymatic processes. C20orf3 promoter-driven reporter assays, which were verified by gene-specific RT-qPCR (real-time quantitative PCR) showed a strong inhibitory effect of human serum on transcription using the HEK-293 human embryonic kidney cell line. In conclusion, we characterized the structure and expression pattern of the C20orf3 gene product. According to a series of analogies with PON (paraoxonase) family members, we speculate that the C20orf3 gene product represents a new member of this important protein family present at the cellular level.
引用
收藏
页码:485 / 495
页数:11
相关论文
共 33 条
[1]   Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization [J].
Aharoni, A ;
Gaidukov, L ;
Yagur, S ;
Toker, L ;
Silman, I ;
Tawfik, DS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :482-487
[2]   Identification of a novel integral plasma membrane protein induced during adipocyte differentiation [J].
Albrektsen, T ;
Richter, HE ;
Clausen, JT ;
Fleckner, J .
BIOCHEMICAL JOURNAL, 2001, 359 :393-402
[3]   Does paraoxonase play a role in susceptibility to cardiovascular disease? [J].
Aviram, M .
MOLECULAR MEDICINE TODAY, 1999, 5 (09) :381-386
[4]   Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development [J].
Aviram, M ;
Rosenblat, M .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (09) :1304-1316
[5]  
Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335
[6]   Secretagogin is a novel marker for neuroendocrine differentiation [J].
Birkenkamp-Demtröder, K ;
Wagner, L ;
Sorensen, FB ;
Astrup, LB ;
Gartner, W ;
Scherübl, H ;
Heine, B ;
Christiansen, P ;
Orntoft, TF .
NEUROENDOCRINOLOGY, 2005, 82 (02) :121-138
[7]   Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites [J].
Boright, AP ;
Connelly, PW ;
Brunt, JH ;
Scherer, SW ;
Tsui, LC ;
Hegele, RA .
ATHEROSCLEROSIS, 1998, 139 (01) :131-136
[8]   Separation and quantitative recovery of mouse serum arylesterase and carboxylesterase activity [J].
Connelly, PW ;
Maguire, GF ;
Draganov, DI .
JOURNAL OF LIPID RESEARCH, 2004, 45 (03) :561-566
[9]   Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities [J].
Draganov, DI ;
Teiber, JF ;
Speelman, A ;
Osawa, Y ;
Sunahara, R ;
La Du, BN .
JOURNAL OF LIPID RESEARCH, 2005, 46 (06) :1239-1247
[10]   Pharmacogenetics of paraoxonases: a brief review [J].
Draganov, DI ;
La Du, BN .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) :78-88